We are live on ! Find out more
RCP

Rho Capital Partners Portfolio holdings

AUM $20.4M
This Fund
S&P 500
This Quarter Est. Return
+3.84%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$256M
AUM Growth
+$61M
Cap. Flow
+$66.3M
Cap. Flow %
25.87%
Top 10 Hldgs %
100%
Holding
7
New
3
Increased
–
Reduced
3
Closed
1

Top Buys

Rank Stock Value
1
EVDY
Everyday Health, Inc.
EVDY
+$81.2M
2
TVRD
Tvardi Therapeutics
TVRD
+$43.8M
3
NRX
NEPHROGENEX INC COM
NRX
+$13.5M

Top Sells

Rank Stock Value
1
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
+$58.2M
2
IL
IntraLinks Holdings Inc.
IL
+$11.9M
3
RLOC
REACHLOCAL INC COM STK (DE)
RLOC
+$2.17M
4
GNVC
GenVec, Inc.
GNVC
+$42K

Sector Composition

Rank Sector Weight
1 Technology 25.92%
2 Healthcare 19.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EVDY
1
DELISTED
Everyday Health, Inc.
EVDY
$82.7M 32.27%
+5,908,432
New +$81.2M
IL
2
DELISTED
IntraLinks Holdings Inc.
IL
$66.4M 25.92%
6,490,503
-1,093,793
-14% -$11.9M
TVRD
3
Tvardi Therapeutics
TVRD
$23.7M
$49.7M 19.38%
+74,113
New +$43.8M
RLOC
4
DELISTED
REACHLOCAL INC COM STK (DE)
RLOC
$25.3M 9.88%
2,570,395
-186,571
-7% -$2.17M
ANAC
5
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$21.4M 8.34%
1,067,892
-3,000,000
-74% -$58.2M
NRX
6
DELISTED
NEPHROGENEX INC COM
NRX
$10.8M 4.2%
+1,326,826
New +$13.5M
GNVC
7
DELISTED
GenVec, Inc.
GNVC
– –
-1,804
Closed -$42K

Similar funds

LUGPI
Lightspeed Ultimate General Partner IX Menlo Park, California $20.3M AUM 4.78% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
DOS
David O. Sacks $19.8M AUM 4.02% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
CVSCT
C.V. Starr & Co Trust New York $19.4M AUM 28.57% 1-Year Est. Return
VNB
Virginia National Bank Charlottesville, Virginia $21.9M AUM 12.04% 1-Year Est. Return
BEP
Brookside Equity Partners Stamford, Connecticut $22.5M AUM 62.43% 1-Year Est. Return

Rho Capital Partners's Q1 2014 Portfolio in Review

As of Q1 2014, Rho Capital Partners held 7 positions worth $256M, up 31% from $195M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Rho Capital Partners deployed $66.3M of net new capital in Q1 2014, opening 3 new positions. Its largest new stake was Everyday Health, Inc.: 5,908,432 shares worth $82.7M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 47% a quarter earlier, followed by Healthcare.

On the sell side, the largest reduction was ANACOR PHARMACEUTICALS INC COM, an estimated $58.2M trimmed.

  • Rho Capital Partners's largest Q1 2014 buy was Everyday Health, Inc.: 5,908,432 shares worth $82.7M.
  • Rho Capital Partners's biggest Q1 2014 reduction was ANACOR PHARMACEUTICALS INC COM, cutting an estimated $58.2M.
  • Rho Capital Partners fully exited GenVec, Inc. in Q1 2014, selling an estimated $42K.
  • Rho Capital Partners's ten largest holdings make up 100% of its $256M portfolio in Q1 2014.
  • Rho Capital Partners opened 3 new positions and closed 1 in Q1 2014.
  • Rho Capital Partners's portfolio value rose 31% quarter-over-quarter to $256M.

Based on Rho Capital Partners's 13F filing for Q1 2014, filed 13 May 2014.